Choate Investment Advisors’s Boston Scientific BSX Stock Holding History

Choate Investment Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$385K	Sell	6,133 -1,011	-14%	-$80.9K	0.01%	334
2025 Q4	$681K	Buy	7,144 +575	+9%	+$56.4K	0.01%	269
2025 Q3	$641K	Buy	6,569 +2,829	+76%	+$293K	0.01%	258
2025 Q2	$402K	Sell	3,740 -24	-0.6%	-$2.43K	0.01%	295
2025 Q1	$380K	Sell	3,764 -320	-8%	-$32.2K	0.01%	291
2024 Q4	$365K	Buy	4,084 +680	+20%	+$59.9K	0.01%	302
2024 Q3	$285K	Buy	3,404 +162	+5%	+$12.8K	0.01%	323
2024 Q2	$250K	Sell	3,242 -23	-0.7%	-$1.68K	0.01%	331
2024 Q1	$224K	Sell	3,265 -380	-10%	-$24.4K	0.01%	380
2023 Q4	$211K	Sell	3,645 -308	-8%	-$16.4K	0.01%	357
2023 Q3	$209K	Buy	+3,953	New	+$207K	0.01%	343

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Choate Investment Advisors's BSX Position: Q1 2026 in Review

Choate Investment Advisors reduced its Boston Scientific (BSX) stake by 14% in Q1 2026, selling an estimated $80.9K and leaving 6,133 shares worth $385K. The position accounts for 0.01% of the portfolio, ranked #334.

Choate Investment Advisors first reported a position in BSX in Q3 2023 and has held it in 11 quarters since. The position peaked at $681K in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Choate Investment Advisors held 6,133 shares of Boston Scientific worth $385K as of Q1 2026.
Choate Investment Advisors sold 1,011 Boston Scientific shares in Q1 2026, an estimated $80.9K.
Boston Scientific made up 0.01% of Choate Investment Advisors's portfolio in Q1 2026, its #334 holding.
Choate Investment Advisors first reported a position in Boston Scientific in Q3 2023 and has held it in 11 quarters since.
Choate Investment Advisors's Boston Scientific position peaked at $681K in Q4 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Choate Investment Advisors's 13F filing for Q1 2026, filed 13 May 2026.